Facile, alternative route to lubeluzole, its enantiomer, and the racemate

Chirality

Volumn 18, Issue 4, 2006, Pages 227-231

  Bruno, Claudio ^a   Carocci, Alessia ^a   Catalano, Alessia ^a   Cavalluzzi, Maria M ^a   Corbo, Filomena ^a   Franchini, Carlo ^a   Lentini, Giovanni ^a   Tortorella, Vincenzo ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Enantiomeric excess; Enantiomers; Sodium channel; Stereospecific synthesis; Stroke

Indexed keywords

BENZOTHIAZOLE DERIVATIVE; LUBELUZOLE; SODIUM CHANNEL;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL STRUCTURE; CHIRALITY; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RACEMIC MIXTURE; STEREOCHEMISTRY; STEREOSPECIFICITY; STROKE; SYNTHESIS; THIN LAYER CHROMATOGRAPHY;

CARDIOVASCULAR AGENTS; MOLECULAR STRUCTURE; PIPERIDINES; STEREOISOMERISM; THIAZOLES;

EID: 33646252005     PISSN: 08990042     EISSN: 1520636X     Source Type: Journal    
DOI: 10.1002/chir.20240     Document Type: Article

References (32)

1. +-channel function as an in vitro model of the ischemic penumbra: action of lubeluzole and other neuroprotective drugs. Brain Res 1997;745:210-221.
2. Grotta J. The efficacy and safety of lubeluzole in patients with acute ischemic stroke. J Neurol Sci 1997;150:S199.
3. De Ryck M, Keersmaekers R, Duytschaever H, Claes C, Clincke G, Janssen M, Van Reet G. Lubeluzole protects sensorimotor function and reduces infarct size in a photochemical stroke model in rats. J Pharmacol Exp Ther 1996;279:748-758.
4. Lesage AS, Peeters L, Leysen JE. Lubeluzole, a novel long-term neuroprotectant, inhibits the glutamate-activated nitric oxide synthase pathway. J Pharmacol Exp Ther 1996;279:759-766.
5. Scheller D, Kolb J, Szathmary S, Zacharias E, De Ryck M, Van Reempts J, Clincke G, Tegtmeier F. Extracellular changes of glutamate in the periinfarct zone: effect of lubeluzole. J Cereb Blood Flow Metab 1995;15(Suppl 1):S379.
6. Culmsee C, Junker V, Wolz P, Semkova I, Krieglstein J. Lubeluzole protects hippocampal neurons from excitotoxicity in vitro and reduces brain damage caused by ischemia. Eur J Pharmacol 1998;342:193-201.
7. + channel blockers in the formalin test. Eur J Pharmacol 2002;445:231-238.
8. Rüdel R, Lehmann-Horn F. Membrane changes in cells from myotonia patients. Physiol Rev 1985;65:310-356.
9. Le Grand B, Talmant J-M, Rieu J-P, Patoiseau J-F, John GW. Study of the interaction of lubeluzole with cardiac sodium channels. J Cardiovasc Pharmacol 2003;42:581-587.
10. De Luca A, Natuzzi F, Falcone G, Duranti A, Lentini G, Franchini C, Tortorella V, Conte Camerino D. Inhibition of frog skeletal muscle sodium channels by newly synthesized chiral derivatives of mexiletine and tocainide. Naunyn Schmiedebergs Arch Pharmacol 1997;356:777-787.
11. De Luca A, Natuzzi F, Desaphy J-F, Loni G, Lentini G, Franchini C, Tortorella V, Conte Camerino D. Molecular determinants of mexiletine structure for potent and use-dependent block of skeletal muscle sodium channels. Mol Pharmacol 2000;57:268-277.
12. Liu H-L, Hoff BH, Berg TC, Anthonsen T. Synthesis of the antistroke drug lubeluzole and its enantiomer. Lipase-catalyzed resolution of chiral building block. Chirality 2001;13:135-139.
13. Still WC, Kahn M, Mitra A. Rapid chromatographic technique for preparative separations with moderate resolution. J Org Chem 1978;43:2923-2925.
14. Neidigh KA, Avery MA, Williamson JS, Bhattacharyya S. Facile preparation of N-methyl secondary amines by titanium (TV) isopropoxide-mediated reductive animation of carbonyl compounds. J Chem Soc Perkin Trans I 1998:2527-2532.
15. 13C chemical shifts of the six-membered ring in benzazoles and 2-substituted N,N-dimethylamino derivatives. Magn Reson Chem 1986;24:415-420.
16. 3; ee 99.9%).
17. Stokbroekx RA, Grauwels GAJ. Preparation of 4-[(2-benzothiazolyl)- methylamino]-α-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol as stroke inhibitor. Eur Pat Appl 501552, 1992
18. Chem Abstr 1993;118:80927.
19. Kumpaty HJ, Williamson JS, Bhattacharyya S. Synthesis of N-methyl secondary amines. Synth Commun 2003;33:1411-1416.
20. Janssens F, Torremans J, Janssen M, Stokbroekx RA, Luyckx M, Janssen PAJ. New antihistaminic N-heterocyclic 4-piperidinamines. 1. Synthesis and antihistaminic activity of N-(4-piperidinyl)-1H-benzimidazol-2-amines. J Med Chem 1985;28:1925-1933.
21. Borch RF, Bernstein MD, Durst HD. The cyanohydridoborate anion as a selective reducing agent. J Am Chem Soc 1971;93:2897-2904.
22. Werbrouck L, Megens AAHP, Stokbroekx RA, Niemegeers CJE. Comparison of the in vivo pharmacological profiles of sabeluzole and its enantiomers. Drug Dev Res 1991;24:41-51.
23. Stokbroekx RA, Luyckx MGM, Janssens FE. Benzoxazol- and benzothiazolamine derivatives. Eur Pat Appl 184257, 1986;
24. Chem Abstr 1987;106:50191.
25. Benassi R, Grandi R, Pagnoni UM, Taddei F, Bocelli G, Sgarabotto P. Conformational properties of the free and methylated 2-amino group in benzimidazole, benzoxazole, and benzothiazole. X-ray crystallographic analysis and nuclear magnetic resonance study of the internal rotation. J Chem Soc Perk Trans II 1985;1513-1521.
26. Mitsunobu O. The use of diethyl azodicarboxylate and triphenylphosphine in synthesis and transformation of natural products. Synthesis 1981;1-28.
27. Chini M, Crotti P, Favero L, Macchia F, Pineschi M. Lanthanide (III) trifluoromethanesulfonates as extraordinarily effective new catalysts for the aminolysis of 1,2-epoxides. Tetrahedron Lett 1994;35:433-436.
28. Di Nunno L, Franchini C, Scilimati A, Sinicropi MS, Tortorella P. Chemical and chemoenzymatic routes to 1-(benzothiazol-2-ylsulfanyl). 3-chloropropan-2-ol, a precursor of drugs with potential β-blocker activity. Tetrahedron: Asymmetry 2000;11:1571-1583.
29. Peeters OM, Blaton NM, De Ranter CJ. (+)-(S)-1-{4-[(2-Benzothiazolyl) (methyl)-amino]piperidyl}-3-(3,4-difluorophenoxy)-2-propanol (Lubeluzole). Acta Crystallogr C 1995;C51:2129-2132.
30. De Camp WH. Letter to the editor. Chirality 1989;1:97-98.
31. Simonyi M, Gal J, Testa B. Signs of the times: the need for a stereochemically informative generic name system. Trends Pharmacol Sci 1989;10:349-354.
32. Van der Goot H, Timmerman H. Identification system for stereoisomeric drugs. Trends Pharmacol Sci 1989;10:486-487.